Navigation Links
deCODE genetics Announces Webcast of Conference Call to Discuss Full-year 2007 Financial Results
Date:3/4/2008

REYKJAVIK, Iceland, March 4 /PRNewswire-FirstCall/ -- deCODE genetics, Inc. (Nasdaq: DCGN) today announced that it will report its full-year 2007 financial results in a press release to be issued on Wednesday, March 12, after the close of the market in New York. The company will host a live webcast of its conference call to discuss these results and recent operating highlights on Thursday, March 13, at 8 am EDT / 12 noon GMT.

The webcast can be accessed through the Investors page of deCODE's website, http://www.decode.com, or through http://www.fulldisclosure.com. Please log in to the webcast 15 minutes prior to the scheduled start of the call. The call will be archived for at least a week on each site. For those unable to listen to the webcast because of company firewall or other issues, a digitized audio replay will also be available by telephone from approximately 10am EDT on Thursday, March 13 and for one week thereafter. The dial-in replay numbers are: 1 (800) 475-6701 in the U.S., and +1 (320) 365-3844 for those calling from outside the U.S. The access code is 914354.

Any statements contained in this presentation that relate to future plans, events or performance are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. These risks and uncertainties include, among others, those relating to technology and product development, integration of acquired businesses, market acceptance, government regulation and regulatory approval processes, intellectual property rights and litigation, dependence on collaborative relationships, ability to obtain financing, competitive products, industry trends and other risks identified in deCODE's filings with the Securities and Exchange Commission. deCODE undertakes no obligation to update or alter these forward-looking statements as a result of new information, future events or otherwise.

Contacts:

deCODE genetics

Kristin H. Barkardottir

+354 570 2847

ir@decode.is


'/>"/>
SOURCE deCODE genetics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. deCODE genetics to Webcast Presentation at BIO CEO and Investor Conference
2. deCODE Discovers Gene Variants that May Help to Distribute the Work of Evolution between Men and Women
3. deCODE genetics to Webcast Presentation at JPMorgan Annual Healthcare Conference
4. deCODE Launches deCODEme(TM)
5. deCODE genetics Announces Third Quarter 2007 Financial Results
6. deCODE genetics Announces Webcast of Conference Call to Discuss Third Quarter 2007 Financial Results
7. deCODE genetics to Webcast Presentation at Thomas Weisel Partners Annual Healthcare Conference
8. Interleukin Genetics Enters into New Clinical Research Collaboration with Alticor
9. CellCyte Genetics Corp. Continues to Move Its Technology Forward in Light of Plaintiff Law Firm Press Releases
10. Smart Genetics Announces Plans to Launch a New Alzheimers Risk Assessment Service
11. Finkelstein Thompson LLP Announces Filing of Securities Fraud Class Action Against CellCyte Genetics Corporation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/22/2017)... DES MOINES, Iowa , Feb. 22, 2017 Origin ... an agricultural biotechnology trait and seed provider, and Arcadia ... -based company that develops and commercializes agricultural productivity traits and ... of a key corn biotechnology product developed in China ... completion of global regulatory trials. ...
(Date:2/22/2017)... ROCHELLE, VIRGINIA (PRWEB) , ... February 22, 2017 ... ... announced today that Dr. Daniel Spyker, PhD, MD former Acting Deputy Director in ... in CDER’s Pilot Drug Evaluation Staff has joined the company as an Expert ...
(Date:2/22/2017)... and SAN DIEGO , ... (the "Company") (OTCQB:CELZ) announced today expansion of its ... stem cell product through establishment of laboratory facilities ... activities at the San Diego BioLabs facility, a ... Ingelheim, Novartis, and Sanofi. In November ...
(Date:2/21/2017)... ROCKVILLE, Md. , Feb. 21, 2017 Synthetic ... therapeutics designed to preserve the microbiome to protect and restore the ... for the year ended December 31, 2016 on Thursday, March 2, ... 4:30 p.m. EST. The dial-in information for the call is as ... ...
Breaking Biology Technology:
(Date:1/31/2017)... 2017  Spero Therapeutics, LLC, a biopharmaceutical company ... of bacterial infections, today announced it has acquired ... Pro Bono Bio Ltd (PBB) to bolster its ... forms of Gram-negative bacteria.   The assets acquired have ... PBB group company. "The acquisition of ...
(Date:1/26/2017)... Jan. 26, 2017  Crossmatch, a leading provider of ... solution aimed at combatting fraud, waste and abuse in ... at the Action on Disaster Relief conference in ... for UN agencies and foreign assistance organizations throughout ... and abuse are a largely unacknowledged problem in the ...
(Date:1/25/2017)... NEW YORK , Jan. 25, 2017 /PRNewswire/ ... and Access Management (IAM) lifecycle is comprised of ... infrastructure for the purpose of maintaining digital identities ... enterprise resources and applications. There are significant number ... compliance from time to time by optimizing processes ...
Breaking Biology News(10 mins):